Published in Clinical Oncology Week, July 10th, 2006
Study 1: Lymphoma treatment outcome could be improved by L-asparaginase-based salvage chemotherapy regimens.
"Midline NK/T-cell lymphoma nasal-type is an aggressive neoplasm with poor prognosis in most instances. To improve the treatment outcome, we have tried using L-asparaginase based regimen as salvage regimen plus radiation in CHOP failures, and report here the therapeutic results and prognostic factors," scientists in the People's Republic of China reported.
"From March 1992 to January 2005, 46 Chinese patients with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.